These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 6992531)

  • 61. Effects of intravenous infusion of prostacyclin (PGI2) in man.
    O'Grady J; Warrington S; Moti MJ; Bunting S; Flower R; Fowle AS; Higgs EA; Moncada S
    Prostaglandins; 1980 Feb; 19(2):319-32. PubMed ID: 6992228
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effect of prostacyclin and 6-keto-PGFl alpha on coronary vascular resistance].
    Boroian RG
    Zh Eksp Klin Med; 1978; 18(4):40-4. PubMed ID: 360725
    [No Abstract]   [Full Text] [Related]  

  • 63. Cardiovascular and antithrombotic effects of ZK 96 480, a novel metabolically stable carbacyclin derivative with oral activity.
    Stürzebecher CS; Loge O; Schröder G; Müller B; Witt W
    Prog Clin Biol Res; 1987; 242():425-31. PubMed ID: 3313417
    [No Abstract]   [Full Text] [Related]  

  • 64. [Mechanism of action of different inhibitors of thrombocyte aggregation].
    Lakin KM; Makarov VA; Novikova NV; Muliar AG
    Vestn Akad Med Nauk SSSR; 1984; (11):54-63. PubMed ID: 6099015
    [No Abstract]   [Full Text] [Related]  

  • 65. Anti-platelet action of intravenous infusion of prostacyclin in man.
    Gryglewski RJ; Szczeklik A; Nizankowski R
    Thromb Res; 1978 Aug; 13(2):153-63. PubMed ID: 358486
    [No Abstract]   [Full Text] [Related]  

  • 66. The orally active thia-imino-prostacyclin Hoe 892: antiaggregatory and cardiovascular activities.
    Schölkens BA; Gehring D; Jung W
    Prostaglandins Leukot Med; 1983 Mar; 10(3):231-56. PubMed ID: 6405394
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thromboxane synthetase inhibition results in increased platelet sensitivity to prostacyclin.
    Bertelé V; Falanga A; Roncaglioni MC; Cerletti C; de Gaetano G
    Thromb Haemost; 1982 Jun; 47(3):294. PubMed ID: 7051411
    [No Abstract]   [Full Text] [Related]  

  • 68. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
    Whittle BJ; Hamid S; Lidbury P; Rosam AC
    Adv Exp Med Biol; 1985; 192():109-25. PubMed ID: 2871707
    [No Abstract]   [Full Text] [Related]  

  • 69. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
    Karim SM; Adaikan PG; Lau LC; Tai MY
    Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prostacyclin infusion in hypertension: acute hemodynamic and hormonal effects.
    Chaignon M; Ruffie ML; Lucsko M; Cuche JL; Guedon J; O'Grady J
    N Engl J Med; 1982 Aug; 307(9):559. PubMed ID: 7048097
    [No Abstract]   [Full Text] [Related]  

  • 72. [Prostacyclin--a new biologically active agent].
    Vapaatalo H
    Duodecim; 1980; 96(3):175-80. PubMed ID: 7004837
    [No Abstract]   [Full Text] [Related]  

  • 73. De-aggregatory action of prostacyclin in vivo and its enhancement by theophylline.
    Gryglewski RJ; Korbut R; Ocetkiewicz A
    Prostaglandins; 1978 Apr; 15(4):637-44. PubMed ID: 353903
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Designing prostacyclin analogues.
    Flohé L; Böhlke H; Frankus E; Kim SM; Lintz W; Loschen G; Michel G; Müller B; Schneider J; Seipp U
    Arzneimittelforschung; 1983; 33(9):1240-8. PubMed ID: 6315026
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Pharmacology of prostacyclin and prostacyclin-like compounds].
    Lakin KM; Baluda VP; Makarov VA
    Vestn Akad Med Nauk SSSR; 1982; (5):81-91. PubMed ID: 7048789
    [No Abstract]   [Full Text] [Related]  

  • 77. Measurement of the disaggregating effect of prostacyclin (PGI2) in anaesthetized dogs.
    Hermán F; Hadházy P; Magyar K
    Biomed Biochim Acta; 1984; 43(8-9):S377-80. PubMed ID: 6393972
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation.
    Gryglewski RJ; Korbut R; Ocetkiewicz A
    Nature; 1978 Jun; 273(5665):765-7. PubMed ID: 351417
    [No Abstract]   [Full Text] [Related]  

  • 79. Comparative effects of prostacyclin (PGI2) and acetate infusions on blood pressure.
    Ward RA; Williams TE; Harding GB
    Trans Am Soc Artif Intern Organs; 1983; 29():33-7. PubMed ID: 6369726
    [No Abstract]   [Full Text] [Related]  

  • 80. [Thrombocyte function and systemic effect of prostaglandin I2 inhalation].
    Silberbauer K; Sinzinger H; Burghuber O; Elliott M; Leithner C; Schernthaner G
    Acta Med Austriaca Suppl; 1979; 6():401-3. PubMed ID: 400370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.